首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Genetic testing of the FBN1 gene in Chinese patients with Marfan/Marfan-like syndrome
【24h】

Genetic testing of the FBN1 gene in Chinese patients with Marfan/Marfan-like syndrome

机译:FBN1基因在中国Marfan / Marfan-like综合征患者中的基因检测

获取原文
获取原文并翻译 | 示例
       

摘要

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder typically involving the ocular, skeletal and cardiovascular systems, and aortic aneurysms/dissection mainly contributes to its mortality. Here, we performed genetic testing of the FBN1 gene in 39 Chinese probands with Marfan/Marfan-like syndrome and their related family members by Sanger sequencing. In total, 29 pathogenic/likely pathogenic FBN1 mutations, including 17 novel ones, were identified. In addition, most MFS patients with aortic disease (62%) had a truncating or splicing mutation. These results expand the FBN1 mutation spectrum and enrich our knowledge of genotype phenotype correlations. Genetic testing for MFS and its related aortic diseases is increasingly important for early intervention and treatment (C) 2016 Elsevier B.V. All rights reserved.
机译:马凡氏综合症(MFS)是常染色体显性结缔组织疾病,通常涉及眼,骨骼和心血管系统,主动脉瘤/解剖主要是导致其死亡的原因。在这里,我们通过Sanger测序对39名患有Marfan / Marfan综合征的中国先证者及其相关家庭成员进行了FBN1基因的基因测试。总共鉴定出29个病原/可能病原的FBN1突变,包括17个新突变。此外,大多数患有主动脉疾病的MFS患者(62%)具有截短或剪接突变。这些结果扩展了FBN1突变谱,丰富了我们的基因型表型相关性知识。 MFS及其相关主动脉疾病的基因检测对于早期干预和治疗越来越重要(C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号